The European Commission (EC) has approved a new Opdivo (nivolumab) formulation associated with a new route of administration ...

Princeton: Bristol Myers Squibb has received approval from the European Commission (EC) for a new Opdivo (nivolumab) ...

Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Thursday, May 29, 2025, 15:0 ...

osimertinib. The PALOMA 3 study was part of a patient-centered program to reduce administration time, exploring the subcutaneous administration route of amivantamab to improve the toxicity profile.

“However, given the inconvenience of intravenous route of administration of infliximab, a subcutaneous formulation could significantly increase convenience for patients with autoimmune ...

The development of inhibitors at 2 different dose levels suggests a potential correlation with the subcutaneous route of administration. This unexpected outcome highlights the complexities ...

VK2735 Presses On With Dual Routes Of Administration As I noted above, the company is pressing on with both the oral and subcutaneous versions of VK2735 for the treatment of patients with obesity.

The results demonstrated that the intradermal dose-saving vaccination route is preferable to the subcutaneous route and that patients in the loCD4 group may require at least one booster to ...